Company Filing History:
Years Active: 1997
Title: Carol Anne DeCann: Innovator in Immunoassay Technology
Introduction
Carol Anne DeCann is a notable inventor based in Rochester, NY (US). She has made significant contributions to the field of clinical diagnostics, particularly in the development of immunoassay technologies. Her work has been instrumental in advancing the accuracy and reliability of diagnostic tests.
Latest Patents
Carol Anne DeCann holds 1 patent for her invention titled "Reduction in first slide bias and improved enzyme stability by a dry immunoassay analytical element for assaying a ligand." This innovative patent focuses on enhancing the performance of immunoassays, which are critical in various medical diagnostics.
Career Highlights
DeCann is currently employed at Johnson & Johnson Clinical Diagnostics, Inc., where she continues to push the boundaries of diagnostic technology. Her expertise and dedication have made her a valuable asset to the company and the field at large.
Collaborations
Throughout her career, Carol has collaborated with esteemed colleagues, including Margaret Elizabeth Logan and Marsha D Oenick. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Carol Anne DeCann's contributions to immunoassay technology exemplify her commitment to improving diagnostic methods. Her innovative spirit and collaborative efforts continue to impact the field positively.